0001493152-17-007275.txt : 20170628 0001493152-17-007275.hdr.sgml : 20170628 20170628170914 ACCESSION NUMBER: 0001493152-17-007275 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20170628 DATE AS OF CHANGE: 20170628 EFFECTIVENESS DATE: 20170628 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Eton Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001710340 IRS NUMBER: 371858472 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-289651 FILM NUMBER: 17936059 BUSINESS ADDRESS: STREET 1: 12264 EL CAMINO REAL CITY: SAN DIEGO STATE: CA ZIP: 92130 BUSINESS PHONE: 858-704-4040 MAIL ADDRESS: STREET 1: 12264 EL CAMINO REAL CITY: SAN DIEGO STATE: CA ZIP: 92130 D 1 primary_doc.xml X0707 D LIVE 0001710340 Eton Pharmaceuticals, Inc. 12264 EL CAMINO REAL SUITE 350 SAN DIEGO CA CALIFORNIA 92130 858-704-4040 DELAWARE None None Corporation true 2017 Sean Brynjelsen 12264 EI Camino Reai Suite 350 San Diego CA CALIFORNIA 92130 Executive Officer Director Mark Baum 12264 EI Camino Real Suite 350 San Diego CA CALIFORNIA 92130 Director Andrew Boll 12264 EI Camino Real Suite 350 San Diego CA CALIFORNIA 92130 Director Charles Casamento 12264 EI Camino Real Suite 350 San Diego CA CALIFORNIA 92130 Director Pharmaceuticals Decline to Disclose 06b false 2017-06-19 false true false 0 National Securities Corporation 7569 None None 410 PARK AVENUE NEW YORK NY NEW YORK 10022 AR ARKANSAS CA CALIFORNIA CO COLORADO FL FLORIDA IL ILLINOIS LA LOUISIANA MD MARYLAND MI MICHIGAN MN MINNESOTA NV NEVADA NJ NEW JERSEY NY NEW YORK PA PENNSYLVANIA TX TEXAS VA VIRGINIA WA WASHINGTON WI WISCONSIN false 20055210 20055210 0 false 230 1958221 0 Recipient also received a warrant to purchase up to 652,740 shares of the Issuer's common stock. 0 false Eton Pharmaceuticals, Inc. /s/ Sean Brynjelsen Sean Brynjelsen Chief Executive Officer 2017-06-28